Anticoagulation care with idarucizumab: Impact beyond the emergency room

Professor Charles Pollack (Professor of Emergency Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, USA) and Associate Professor Anna Tomaszuk-Kazberuk (Lecturer and Consultant, Department of Cardiology, University Hospital, Bialystok, Poland) discuss the impact idarucizumab (Praxbind^®) has had on emergency medicine and the use of dabigatran (Pradaxa^®) in the management of anticoagulation care for patients with atrial fibrillation.